Covered recipient · General Payments record
KIMBERLY H WEST
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,148.02
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $514.55 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $155.02 | 11 |
| ABBVIE INC. | $101.01 | 4 |
| Acerta Pharma LLC | $68.41 | 3 |
| Exact Sciences Corporation | $61.66 | 2 |
| Amgen Inc. | $59.59 | 3 |
| Lilly USA, LLC | $33.75 | 2 |
| PFIZER INC. | $19.76 | 1 |
| Astellas Pharma US Inc | $15.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.46 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108398459 | CMS |
| ABBVIE INC. | $31.65 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108398461 | CMS |
| ABBVIE INC. | $16.00 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108398463 | CMS |
| ABBVIE INC. | $33.90 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108398465 | CMS |
| Amgen Inc. | $23.75 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117413051 | CMS |
| Amgen Inc. | $20.22 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117716314 | CMS |
| Amgen Inc. | $15.62 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117413053 | CMS |
| Astellas Pharma US Inc | $15.35 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139534624 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.31 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104497556 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.52 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104211061 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.58 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104269941 | CMS |
| Exact Sciences Corporation | $28.22 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114464019 | CMS |
| Exact Sciences Corporation | $33.44 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114464026 | CMS |
| Lilly USA, LLC | $16.35 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135780186 | CMS |
| Lilly USA, LLC | $17.40 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135772198 | CMS |
| Novo Nordisk Inc | $5.74 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100265164 | CMS |
| Novo Nordisk Inc | $2.96 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100322658 | CMS |
| Novo Nordisk Inc | $5.98 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100499551 | CMS |
| Novo Nordisk Inc | $23.80 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100350124 | CMS |
| Novo Nordisk Inc | $22.84 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100368219 | CMS |
| Novo Nordisk Inc | $18.33 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100226984 | CMS |
| Novo Nordisk Inc | $9.67 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100330942 | CMS |
| Novo Nordisk Inc | $21.21 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100333409 | CMS |
| Novo Nordisk Inc | $23.81 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100589029 | CMS |
| Novo Nordisk Inc | $3.91 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100588415 | CMS |
| Novo Nordisk Inc | $16.77 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100596437 | CMS |
| PFIZER INC. | $19.76 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131619900 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.